The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 501–600 of 1,008
Luo, Q., Hu, D., Hu, S., Yan, M., Sun, Z., & Chen, F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-517 · Cited by 87
Metformin promotes isolated rat liver mitochondria impairment
Carvalho, C., Correia, S. C., Santos, M. S., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9614-3 · Cited by 88
Ageing and metabolism: drug discovery opportunities
Curtis, R., Geesaman, B. J., & DiStefano, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1777 · Cited by 86
AMP-Activated Protein Kinase: A New Beta-Cell Glucose Sensor?
Leclerc, I., & Rutter, G. A. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s67 · Cited by 91
Metformin induces PGC‐1α expression and selectively affects hepatic PGC‐1α functions
Aatsinki, S., Buler, M., Salomäki, H., Koulu, M., Pavek, P., & Hakkola, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12585 · Cited by 85
Quinn, B. J., Dallos, M., Kitagawa, H., Kunnumakkara, A. B., Memmott, R. M., Hollander, M. C., Gills, J. J., & Dennis, P. A. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0058-t · Cited by 85
Syrosingopine sensitizes cancer cells to killing by metformin
Benjamin, D., Colombi, M., Hindupur, S. K., Betz, C., Lane, H. A., El‐Shemerly, M., Lu, M., Quagliata, L., Terracciano, L., Moes, S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1601756 · Cited by 89
Mitochondrial heterogeneity in diseases
Chen, L., Zhou, M., Li, H., Liu, D., Liao, P., Yao, Z., Zhang, C., Zou, W., & Gao, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01546-w · Cited by 88
Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
Oh, S., Mai, X. L., Kim, J., de Guzman, A. C. V., Lee, J. Y., & Park, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01222-1 · Cited by 93
Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication
Protti, A., Russo, R., Tagliabue, P. F., Vecchio, S., Singer, M., Rudiger, A., Foti, G., Rossi, A., Mistraletti, G., & Gattinoni, L. (2010) · Critical Care · doi:10.1186/cc8885 · Cited by 85
Banerjee, J., Bruckbauer, A., & Zemel, M. B. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.011 · Cited by 85
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 87
Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity
Avagliano, A., Ruocco, M. R., Aliotta, F., Belviso, I., Accurso, A., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Cells · doi:10.3390/cells8050401 · Cited by 88
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 88
Calcium Signaling in Liver Injury and Regeneration
Oliva‐Vilarnau, N., Hankeová, S., Vorrink, S. U., Mkrtchian, S., Andersson, E. R., & Lauschke, V. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00192 · Cited by 85
Structural Insight into AMPK Regulation: ADP Comes into Play
Jin, X., Townley, R. A., & Shapiro, L. S. (2007) · Structure · doi:10.1016/j.str.2007.07.017 · Cited by 88
Rencurel, F., Foretz, M., Kaufmann, M., Stroka, D., Looser, R., Leclerc, I., Xavier, G. D. S., Rutter, G. A., Viollet, B., & Meyer, U. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029421 · Cited by 85
Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
Brittain, E. L., Niswender, K. D., Agrawal, V., Chen, X., Fan, R., Pugh, M. E., Rice, T. W., Robbins, I. M., Song, H., Thompson, C., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018349 · Cited by 88
Metformin and prostate cancer stem cells: a novel therapeutic target
Mayer, M., Klotz, L. H., & Venkateswaran, V. K. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.35 · Cited by 85
Solskov, L., Løfgren, B., Kristiansen, S. B., Jessen, N., Pold, R., Nielsen, T. T., Bøtker, H. E., Schmitz, O., & Lund, S. A. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00234.x · Cited by 83
Zhang, T., Guo, P., Zhang, Y., Xiong, H., Yu, X., Xu, S., Wang, X., He, D., & Jin, X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224603 · Cited by 84
Metabolic Profiles Associated With Metformin Efficacy in Cancer
Andrzejewski, S., Siegel, P. M., & St‐Pierre, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00372 · Cited by 85
Boyle, J. G., Salt, I. P., & McKay, G. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03098.x · Cited by 83
Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
Ricci, J., & Chiche, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00556 · Cited by 87
Lac-Phe mediates the effects of metformin on food intake and body weight
Xiao, S., Li, V. L., Lyu, X., Chen, X., Wei, W., Abbasi, F., Knowles, J. W., Tung, A. S.-H., Deng, S., Tiwari, G., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00999-9 · Cited by 85
Impact of metformin on peak aerobic capacity
Braun, B., Eze, P. N., Stephens, B. R., Hagobian, T. A., Sharoff, C. G., Chipkin, S. R., & Goldstein, B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-144 · Cited by 84
Linden, M. A., Fletcher, J. A., Morris, E. M., Meers, G. M.-E., Kearney, M. L., Crissey, J. M., Laughlin, M. H., Booth, F. W., Sowers, J. R., Ibdah, J. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2013 · Cited by 83
Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited
Li, Z., Ji, B. W., Dixit, P. D., Tchourine, K., Lien, E. C., Hosios, A. M., Abbott, K. L., Rutter, J. C., Westermark, A. M., Gorodetsky, E. F., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00588-8 · Cited by 81
Metformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration
Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia · doi:10.1007/s00125-011-2340-0 · Cited by 81
Samuel, S., Varghese, E., Kubatka, P., Triggle, C., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120846 · Cited by 81
Lee, J. W., Shin, Y.-J., Kim, H., Kim, H., Kim, J., Min, S.-A., Kim, P., Yu, S. D., & Park, K. (2018) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2018.12.084 · Cited by 83
The multifaceted effects of metformin on tumor microenvironment
Kurelac, I., Ganesh, N. U., Iorio, M. C., Porcelli, A. M., & Gasparre, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.010 · Cited by 81
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Reyes‐Castellanos, G., Masoud, R., & Carrier, A. (2020) · Biomedicines · doi:10.3390/biomedicines8080270 · Cited by 85
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 89
Selective Inhibition of Deactivated Mitochondrial Complex I by Biguanides
Matsuzaki, S., & Humphries, K. M. (2015) · Biochemistry · doi:10.1021/bi501473h · Cited by 81
Ismaiel, A. A., Espinosa‐Oliva, A. M., Santiago, M., García-Quintanilla, A., Oliva-Martín, M. J., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.004 · Cited by 81
Bridges, H. R., Sirviö, V. A., Agip, A.-N. A., & Hirst, J. (2016) · BMC Biology · doi:10.1186/s12915-016-0287-9 · Cited by 82
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Meena, A. S., & Bhat, M. K. (2015) · Oncotarget · doi:10.18632/oncotarget.6134 · Cited by 80
Sumi, C., Okamoto, A., Tanaka, H., Nishi, K., Kusunoki, M., Shoji, T., Uba, T., Matsuo, Y., Adachi, T., Hayashi, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192796 · Cited by 84
Metformin in Pregnancy: Mechanisms and Clinical Applications
Hyer, S. L., Balani, J., & Shehata, H. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 87
General aspects of muscle glucose uptake
Alvim, R. D. O., CHEUHEN, M. R., MACHADO, S. R., de Sousa, A. G. P., & SANTOS, P. C. J. L. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140225 · Cited by 92
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Grisouard, J., Timper, K., Radimerski, T., Frey, D. M., Peterli, R., Kola, B., Korbonits, M., Herrmann, P. C., Krähenbühl, S., Zulewski, H., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.021 · Cited by 82
Park, J., Kim, Y., Park, E. H., Lee, S., Kim, H. W., Kim, A., Lee, S. B., Shim, S., Jang, H., Myung, J. K., et al. (2019) · Cancer Science · doi:10.1111/cas.14124 · Cited by 79
Mandal, J., Shiue, C.-N., Chen, Y.-C., Lee, M., Yang, H., Chang, H., Hu, C., Liao, P.-C., Hui, L.-C., You, R.-I., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.003 · Cited by 79
Emodin Regulates Glucose Utilization by Activating AMP-activated Protein Kinase*
Song, P., Kim, J. H., Ghim, J., Yoon, J. H., Lee, A., Kwon, Y., Hyun, H., Moon, H. Y., Choi, H., Berggren, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441477 · Cited by 80
Central Role of 5′-AMP-Activated Protein Kinase in Chicken Sperm Functions1
Nguyen, T. M. D., Alves, S., Grasseau, I., Métayer, S., Praud, C., Froment, P., & Blesbois, É. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121855 · Cited by 81
DePeralta, D. K., Wei, L., Ghoshal, S., Schmidt, B. H., Lauwers, G. Y., Lanuti, M. D., Chung, R. T., Tanabe, K. K., & Fuchs, B. C. (2016) · Cancer · doi:10.1002/cncr.29912 · Cited by 80
Zhang, K., Yang, W., Dai, H., & Deng, Z. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108001 · Cited by 80
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Wang, N., Wang, B., Maswikiti, E. P., Yu, Y., Song, K., Ma, C., Han, X., Ma, H., Deng, X., Yu, R., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02011-5 · Cited by 83
Tosca, L., Froment, P., Ramé, C., McNEILLY, J. R., McNeilly, A. S., Maillard, V., & Dupont, J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.087023 · Cited by 83
Iron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 81
Shafiei‐Irannejad, V., Samadi, N., Yousefi, B., Salehi, R., Velaei, K., & Zarghami, N. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13078 · Cited by 78
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N. A., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 78
EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?
López, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0927 · Cited by 78
Wróbel, M. P., Marek, B., Kajdaniuk, D., Rokicka, D., Szymborska‐Kajanek, A., & Strojek, K. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0050 · Cited by 77
Ming, M., Sinnett‐Smith, J. W., Wang, J., Soares, H. P., Young, S. H., Eibl, G., & Rozengurt, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114573 · Cited by 78
Krishan, S., Richardson, D. R., & Sahni, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095810 · Cited by 80
Chronic activation of AMP-activated kinase as a strategy for slowing aging
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.043 · Cited by 77
Morgillo, F., Fasano, M., Della Corte, C. M., Sasso, F. C., Papaccio, F., Viscardi, G., Esposito, G., Di Liello, R., Normanno, N., Capuano, A., et al. (2017) · ESMO Open · doi:10.1136/esmoopen-2016-000132 · Cited by 76
Protective effect of metformin against palmitate-induced hepatic cell death
Geng, Y., Villanueva, A. H., Oun, A., Buist‐Homan, M., Blokzijl, H., Faber, K. N., Dolga, A. M., & Moshage, H. J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165621 · Cited by 76
Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
Jiating, L., Buyun, J., & Zhang, Y. (2019) · BioMed Research International · doi:10.1155/2019/9203934 · Cited by 80
Caloric restriction and chronic inflammatory diseases
González, O. A., Tobia, C. M., Ebersole, J. L., & Novak, M. J. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01830.x · Cited by 81
A whole-organism screen identifies new regulators of fat storage
Lemieux, G. A., Liu, J., Mayer, N., Bainton, R. J., Ashrafi, K., & Werb, Z. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.534 · Cited by 80
AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis
Wang, Y., Qu, X., Yang, Y., Han, X., Wang, L., Qiao, H., Fan, Q., Tang, T., & Dai, K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.004 · Cited by 76
lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
Liu, X., & Gan, B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1249545 · Cited by 77
Metformin as a Therapeutic Target in Endometrial Cancers
Lee, T. Y., Martinez‐Outschoorn, U., Schilder, R. J., Kim, C. H., Richard, S. D., Rosenblum, N. G., & Johnson, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00341 · Cited by 76
Donnan, K., & Segar, L. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.002 · Cited by 79
Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies
Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M., & Oliveira, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.005 · Cited by 81
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Hsu, W., Hsiao, P., Lin, P.-C., Chen, S., Lee, M., & Shin, S. (2017) · Oncotarget · doi:10.18632/oncotarget.23387 · Cited by 75
Benedetti, R., Benincasa, G., Glass, K., Chianese, U., Vietri, M. T., Congi, R., Altucci, L., & Claudio Napoli, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106039 · Cited by 75
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 81
Hinke, S. A., Martens, G. A., Cai, Y., Finsi, J., Heimberg, H., PIPELEERS, D. G., & de Casteele, M. V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707189 · Cited by 76
The AMP-regulated kinase family: Enigmatic targets for diabetes therapy
Rutter, G. A., & Leclerc, I. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.020 · Cited by 75
Paiva, M. S. A., Gonçalves, L. M. M., Providência, L. A., Davidson, S. M., Yellon, D. M., & Mocanu, M. M. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6222-3 · Cited by 80
Li, X., Li, J., Wang, L., Li, A., Qiu, Z., Qi, L., Kou, J., Liu, K., Liu, B., & Huang, F. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13493 · Cited by 76
Organismal Carbohydrate and Lipid HomeostasisPreprint
Hardie, D. G. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006031 · Cited by 82
Li, P., Zhao, M., Parris, A. B., Feng, X., & Yang, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.117 · Cited by 74
A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
Joshua, A. M., Zannella, V. E., Downes, M. R., Bowes, B., Hersey, K. M., Koritzinsky, M., Schwab, M. G., Hofmann, U., Evans, A., van der Kwast, T., et al. (2014) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.20 · Cited by 75
Lahiguera, Á., Hyroššová, P., Figueras, A., Garzón, D., Moreno‐Justicia, R., Soto‐Cerrato, V., McNeish, I. A., Serra, V., Lázaro, C., Barretina-Ginesta, M.-P., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911217 · Cited by 77
Lactate and Myocardiac Energy Metabolism
Dong, S., Qian, L., Cheng, Z., Chen, C., Wang, K., Hu, S., Zhang, X., & Wu, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715081 · Cited by 76
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Zemel, M. B., & Bruckbauer (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s40840 · Cited by 74
Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
Paiva, M. S. A., Riksen, N. P., Davidson, S. M., Hausenloy, D. J., Monteiro, P. F., Gonçalves, L. M. M., Providência, L. A., Rongen, G. A. P. J. M., Smits, P., Mocanu, M. M., et al. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819fd4e7 · Cited by 76
AMP-activated protein kinase: Structure, function, and role in pathological processes
Novikova, D., Garabadzhiu, A. V., Melino, G., Barlev, N. A., & Tribulovich, V. G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915020017 · Cited by 77
Dokladda, K., Green, K. A., Pan, D. A., & Hardie, D. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.084 · Cited by 74
Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003126 · Cited by 73
Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Andersen, J. L., Madsbad, S., Worm, D., Helge, J. W., & Dela, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2098-4 · Cited by 73
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Sena, L. A., & Denmeade, S. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1392 · Cited by 78
The LKB1-AMPK Pathway—Friend or Foe in Cancer?
Hardie, D. G. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.009 · Cited by 81
EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer
Zhang, J., Wang, C., Chen, X., Takada, M., Fan, C., Zheng, X., Wen, H., Liu, Y., Wang, C., Pestell, R. G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591437 · Cited by 76
Gillespie, Z. E., Pickering, J., & Eskiw, C. H. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00142 · Cited by 74
Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer
Boukalová, Š., Štursa, J., Werner, L., Ezrova, Z., Černý, J., Bezawork‐Geleta, A., Pecinová, A., Dong, L., Drahota, Z., & Neužil, J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-1021 · Cited by 76
Li, Y., Wang, M., Zhi, P., You, J., & Gao, J. (2017) · Oncotarget · doi:10.18632/oncotarget.23187 · Cited by 75
Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
Postler, T. S., Peng, V., Bhatt, D. M., & Ghosh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-97441-x · Cited by 73
Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
Baur, J. A., & Birnbaum, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.013 · Cited by 72
Kamiński, M. M., Röth, D., Krammer, P. H., & Gülow, K. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0235-0 · Cited by 73
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
Leidgens, V., Proske, J., Rauer, L., Moeckel, S., Renner, K., Bogdahn, U., Riemenschneider, M. J., Proescholdt, M. A., Vollmann‐Zwerenz, A., Hau, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14159 · Cited by 73
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer
Khan, A., & Frigo, D. E. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2016.272 · Cited by 74
Kato, H., Sekine, Y., Furuya, Y., Miyazawa, Y., Koike, H., & Suzuki, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.178 · Cited by 71
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
